6-Iodo-3-(o-tolyl)-[1,2,4]triazolo[4,3-a]pyridine (10)

TJ Thomas R. Jackson
AV Aini Vuorinen
LJ Laia Josa-Culleré
KM Katrina S. Madden
DC Daniel Conole
TC Thomas J. Cogswell
IW Isabel V.L. Wilkinson
LK Laura M. Kettyle
DZ Douzi Zhang
AO Alison O’Mahony
DG Deanne Gracias
LM Lorna McCall
RW Robert Westwood
GT Georg C. Terstappen
SD Stephen G. Davies
ET Edward W. Tate
GW Graham M. Wynne
PV Paresh Vyas
AR Angela J. Russell
TM Thomas A. Milne
ask Ask a question
Favorite

To a suspension of hydrazine 8 (875 mg, 3.72 mmol) in EtOH (12 mL) was added 2-methylbenzaldehyde (447 mg, 3.72 mmol). The mixture was heated to reflux for 2 h, then cooled to room temperature. The resulting solid was filtered and washed with EtOH to give the hydrazone 9. To a suspension of the crude hydrazone 9 in anhydrous CH2Cl2/MeOH (10:2, 19 mL) was added (diacetoxyiodo)benzene (1.68 g, 5.21 mmol) at 0°C. The mixture was stirred at room temperature overnight, then diluted with water, extracted with CH2Cl2 and dried over anhydrous Na2SO4. The crude product was purified using flash column chromatography to give the triazolopyridine 10 (748 mg, 2.23 mmol, 60%) as an off-white solid. 1H NMR (500 MHz, CDCl3) δ 8.03 (t, J = 1.3 Hz, 1H), 7.61 (dd, J = 9.6, 1.0 Hz, 1H), 7.47 (td, J = 7.5, 1.5 Hz, 1H), 7.44–7.39 (m, 3H), 7.37 (t, J = 7.4 Hz, 1H), 2.25 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 148.5, 145.8, 138.7, 135.1, 131.3, 130.8, 130.2, 127.6, 126.4, 125.0, 117.5, 77.7, 19.9; m/z (ESI+) 336.0 ([M + H]+, 100%); HRMS (ESI+) C13H11N3I+ ([M + H]+) requires 335.9992; found 335.9988.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A